Antietanol

Quick links to important sections

Antietanol

Treatment option: Alcoholism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antietanol

Property Description
Active Ingredient Disulfiram (C10H20N2S4)
Form Oral Tablet (Single-Ingredient)
Pharmacological Class Aldehyde Dehydrogenase Inhibitor
Common Use Management of Chronic Alcoholism
Origin Synthetic (Carbamatine derivative)

Antietanol: Definition and Primary Pharmaceutical Identity

Antietanol is a prescription-only medication primarily employed as a supportive tool in the management of Chronic Alcoholism and Alcohol Use Disorder (AUD). Its single active ingredient is Disulfiram, a synthetic chemical entity categorized as a carbamatine derivative. The drug is supplied for oral administration, typically as an oral tablet, and is utilized to aid patients committed to achieving long-term abstinence. The established utility of Disulfiram in this area has been consistently documented across several decades of clinical practice, distinguishing it as one of the most recognized pharmacological aids in Medication-Assisted Treatment (MAT) for AUD.

What Pharmacological Class Does Antietanol Belong To?

Antietanol is fundamentally categorized as an Aldehyde Dehydrogenase Inhibitor (ALDH inhibitor), which also places it in the functional class of an Alcohol Aversive Agent. This classification reflects its unique mechanism of action, which involves the irreversible inhibition of the enzyme Aldehyde Dehydrogenase in the liver. This enzymatic blockade disrupts alcohol metabolism, leading to the necessary basis for the powerful deterrent effect.

The General Purpose of Antietanol in Alcohol Use Management

The general purpose of Antietanol is to act as a definitive chemical deterrent that creates a predictable, highly unpleasant physical reaction should any alcohol be consumed. This powerful aversive mechanism serves to reinforce the patient's commitment to avoiding alcohol ingestion. The medication's role is to support the patient's willpower by introducing a chemical barrier, allowing motivated individuals to succeed in maintaining enforced sobriety and achieving abstinence.

What side effects are possible with Antietanol?

Antietanol: Possible Side Effects and Safety Information

The safety profile of Antietanol, which contains Disulfiram, is structured around the immediate, severe consequences of consuming alcohol and the risk of specific systemic adverse reactions documented in regulatory records.

Key Adverse Reaction Domains

Domain Characteristic Reactions Frequency Classification
Disulfiram-Alcohol Reaction (DAR) Severe flushing, headache, nausea, vomiting, chest pain, hypotension, potential cardiovascular collapse. This reaction is certain upon alcohol exposure.
Neurological System Headache, drowsiness, fatigue, peripheral neuropathy, optic neuritis. Headache and drowsiness are common; neuropathies are rare/uncommon.
Hepatobiliary System Elevated liver enzymes, hepatitis, jaundice, and potential hepatic failure. Hepatotoxicity, including fatal cases, is considered rare but serious.

The most prominent safety characteristic is the Disulfiram-Alcohol Reaction (DAR), an acute, potentially life-threatening systemic response that occurs upon ingestion of any form of alcohol while the drug is active in the body. This reaction establishes the major constraint on its use.

Regulatory Safety Notes

Adverse effects are officially categorized, with common reactions typically including headache, metallic or garlic-like aftertaste, fatigue, and decreased libido. Serious adverse reactions documented in official prescribing information include severe hepatotoxicity, peripheral neuropathy, and psychotic reactions.

Time-related patterns state that drowsiness and fatigue may be more pronounced at the start of treatment, while severe effects like hepatic damage or neuropathy are associated with prolonged exposure.

The medicine is contraindicated in patients with severe myocardial disease, uncompensated cardiac failure, psychoses, and severe hepatic impairment. Due to the risk of hepatotoxicity, routine monitoring of liver function tests is a mandated safety requirement.

Overdose and Emergency Response

Antietanol Overdose and When to Seek Help

An overdose of Antietanol requires immediate emergency medical attention as it can lead to severe toxicity and life-threatening complications. The toxic effects are primarily caused by the buildup of harmful metabolic by-products, which can affect multiple organ systems.

Overdose Symptoms

Symptoms of Antietanol toxicity typically progress in stages and may include:

  • Initial Stage (Similar to Alcohol Intoxication): Dizziness, poor coordination, slurred speech, nausea, and vomiting.
  • Intermediate Stage: Rapid breathing, elevated heart rate, high blood pressure, and profound metabolic acidosis (excess acid in the blood and tissues).
  • Late Stage (Severe Toxicity): Seizures, decreased level of consciousness (stupor or coma), kidney failure (decreased or absent urine output), and permanent organ damage, including potential blindness or death.

When to Seek Emergency Help

Call 911 or your local emergency number immediately if you suspect an Antietanol overdose. Do not wait for symptoms to worsen. Time is critical for effective treatment. Treatment in a hospital setting typically involves supportive care and administering a specific antidote (such as fomepizole) to prevent the formation of toxic metabolites. In severe cases, hemodialysis may be necessary to remove the poison and its by-products from the bloodstream. Always provide the healthcare provider with information about the amount ingested and when the event occurred.


Therapeutic Uses of Antietanol

What Antietanol Treats: Main Uses and Benefits

Antietanol is commonly used in the management of Chronic Alcoholism and Alcohol Use Disorder (AUD), and is applied in addressing the core condition of impaired control over alcohol use. This medication supports patients who are seeking to establish and maintain sobriety, particularly those with a high risk of relapse or moderate to severe AUD. Within these clinical contexts, it is utilized as a primary tool for the treatment of chronic alcoholism.


Therapeutic Focus and Patient Benefit

Antietanol generally supports the patient's commitment to recovery by providing a chemical deterrent, and generally helps to support abstinence. This allows the patient to better focus on concurrent counseling and behavioral therapies. Its primary indications include the pharmacological support of abstinence in chronic AUD, reduction of relapse vulnerability, and integration into Medication-Assisted Treatment (MAT) Programs. It generally supports patients by offering a chemical barrier that complements concurrent counseling and behavioral therapies, and assists with maintaining functional stability during recovery.


Quick Fact: Support for Relapse Vulnerability

Antietanol is considered relevant in clinical settings characterized by this major symptom cluster of severe dependence, as it may assist with easing the symptom load associated with the difficulty of remaining alcohol-free during long-term recovery efforts.

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Eligibility: Official Regulatory Information

Antietanol (Disulfiram) is approved for use in certain adult patients, but its use is strictly limited by a number of formal contraindications based on regulatory labeling. These rules define who can safely receive the medicine.

Populations Who Must Not Use Antietanol (Contraindicated):

The medicine is formally prohibited for patients who are currently receiving or have recently received metronidazole or paraldehyde, or any products containing alcohol (such as certain cough syrups or tonics).

Contraindications also apply to individuals with certain pre-existing conditions:

Condition Type Specific Contraindication
Cardiovascular Severe myocardial disease or coronary occlusion
Psychiatric Psychoses
Allergy Hypersensitivity to Antietanol or other thiuram derivatives

Eligibility is limited to those who do not have these conditions and have not had recent exposure to the specified substances. If you fall into any of the contraindicated groups, Antietanol must not be used.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interaction patterns for Antietanol (Disulfiram) based strictly on government regulatory sources.


Formal Contraindicated Combinations

Co-administration is formally contraindicated with the following substances due to the risk of severe adverse reactions, as documented in regulatory labeling:

  • Alcohol and Alcohol-Containing Preparations: This includes beverages, foods, and external products (e.g., mouthwash, aftershave). The consumption of alcohol must be avoided for at least 14 days after discontinuing Antietanol.
  • Metronidazole: Concomitant use is contraindicated due to reports of acute psychoses and confusion.
  • Paraldehyde: Concurrent use is formally prohibited.

Documented Exposure-Altering Interactions

Antietanol is officially described as decreasing the rate at which certain drugs are metabolized, potentially leading to increased blood levels and toxicity of the co-administered drug. These include:

  • Phenytoin (and congeners): Inhibition of hepatic metabolism may result in Phenytoin intoxication. Serum levels must be determined and closely monitored.
  • Oral Anticoagulants (e.g., Warfarin): Antietanol may prolong prothrombin time, which requires monitoring and potential dosage adjustment.
  • Theophylline: Clearance may be reduced, requiring monitoring of serum levels.

Other Documented Interactions

  • Pharmacodynamic Effects: Co-administration with Isoniazid may be associated with unsteady gait or changes in mental status. Antietanol may also add to the effects of other Central Nervous System (CNS) Depressants.
  • Population-Specific Cautions: Extreme caution is advised in patients with existing Hepatic Impairment due to the association with hepatotoxicity.

Mechanism of Action

How Antietanol Works

Enzyme Inhibition Blocks Ethanol Catabolism

Antietanol exerts its primary pharmacodynamic mechanism by acting as an irreversible inhibitor of the enzyme aldehyde dehydrogenase (ALDH), which is crucial for the second stage of ethanol breakdown. This binding permanently inactivates ALDH, preventing the metabolic conversion of the toxic compound acetaldehyde into acetate. Following ethanol consumption, this enzyme inactivation causes acetaldehyde to accumulate rapidly in the systemic circulation, triggering a profound systemic physiological alteration that is the primary source of the compound's observed physiological consequences.

Modulating Neurotransmitter Balance

A secondary mechanism involves the inhibition of dopamine beta-hydroxylase (DBH), an enzyme that converts the neurotransmitter dopamine into norepinephrine within both central and peripheral pathways. This action alters the ratio of these key catecholamine neurotransmitters, influencing subsequent neural activity and contributing to the altered systemic physiological status.

Dosage and Administration Information

Official Administration Guidelines

Antietanol (Disulfiram) is used strictly according to official prescribing information and must never be administered while the patient is in a state of alcohol intoxication or without their full knowledge.

Administration Scope Detail
Route of Administration Oral administration only, typically using a tablet form.
Dosing Schedule Initial Dose: A maximum of 500 mg taken once daily for the first one to two weeks. Maintenance Dose: The average dose is 250 mg daily, within a typical range of 125 mg to 500 mg.
Timing in Relation to Meals May be taken in the morning; however, administration may be shifted to bedtime if the patient experiences a sedative effect.
Preparation Requirements Tablets may be crushed and thoroughly mixed with liquids, such as water, coffee, tea, milk, or juice, to ensure administration compliance.
Age-Group Rules Older Adults: Dose selection should be cautious, starting at the low end of the dosing range. Pediatric: Safety and effectiveness have not been established.
Missed-Dose Rules The regimen requires uninterrupted daily administration; generally, the patient is advised to resume the regular schedule, avoiding double doses.

Special Procedural Conditions

Daily therapy must be preceded by complete abstinence from alcohol for at least 12 hours prior to the initial dose. The daily, uninterrupted administration of Antietanol must be continued for a sufficient duration, which may span months or even years, until a basis for permanent self-control has been established. The potential for an alcohol reaction persists for up to 14 days after the last dose is taken.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Antietanol

Evidence for Use in Chronic Alcoholism and Alcohol Use Disorder (AUD)

This section summarizes the types of clinical trials, systematic reviews, and observational studies that have examined Antietanol's use in patients pursuing abstinence from alcohol. Research was studied for its use in adults diagnosed with Alcohol Use Disorder (AUD) or Chronic Alcoholism. Research examined outcomes related to abstinence from alcohol. Researchers monitored outcomes such as the achievement of continuous abstinence rates and the measurement of time elapsed until the first instance of relapse back to drinking. Studies also monitored overall alcohol consumption patterns, including the number of drinking days. The evidence contributes to understanding symptom patterns related to difficulty maintaining sobriety.

Study Designs: Randomized Trials and the Role of Supervision

The research base includes different types of trials, such as Randomized Controlled Trials (RCTs), where patients were randomly assigned to groups, and open-label studies where participants knew what they were taking. A key area of research examined the patterns observed when administration of the medication was directly supervised by a clinical team versus when patients took the medication without supervision. Findings were mixed when comparing the reported outcomes of the supervised trials versus those where the participants were blinded to whether they received the medication or a placebo. The patterns reported in the research were associated with the study conditions, particularly supervision.

Long-Term Studies and Follow-up Durations

Research has explored short-term symptom changes, with follow-up periods in many studies lasting 12 weeks or less. Studies have also tracked patients over intermediate periods, such as up to one year. Some naturalistic and extended observational research has monitored participants for longer periods, sometimes up to 2.5 or 3 years. These studies describe the patterns observed over defined time intervals. However, comprehensive, long-term effects are not fully established by a consistent body of randomized trial data.

Evidence in Specific Patient Populations

The majority of research was evaluated in adult patients with Alcohol Use Disorder who were observed in settings where they expressed a strong commitment to abstinence. Research has explored outcomes in specific subgroups, including those with co-occurring psychiatric conditions (sometimes called dual diagnosis), and findings describe patterns observed in these studies. Currently, data are still emerging regarding the consistency of outcomes across all patient groups, and data for certain groups remain insufficient. For instance, specific research focusing only on older adults is limited, and the study results reflect the specific conditions under which they were conducted.

What is Still Uncertain About Antietanol’s Research Base

The research highlights what is known—and what is still uncertain. One significant factor is that the measured outcomes are highly reliant on patient adherence, and studies exploring non-supervised use show patterns related to this challenge. Evidence quality varies across studies, and many older trials had sample sizes that were modest. Furthermore, the inconsistency of results observed when comparing blinded studies to open-label studies is an area where certainty remains low. There is also limited information for long-term outcomes regarding the maintenance of continuous abstinence, and this represents a key research gap. The available research does not determine whether an individual will respond similarly to the group patterns reported in the trials.

Key Studies & References Disulfiram (Antabuse) Drug Information, Clinical Summary

Frequently Asked Questions (FAQ)

Common questions about Antietanol (FAQ)

Q: Is Antietanol the same as Disulfiram, or is it a similar medication?

Antietanol is a specific name for a medication whose active ingredient is Disulfiram. Official regulatory documents classify it as an Alcohol Aversive Agent or an Aldehyde Dehydrogenase Inhibitor. This classification reflects its unique mechanism of blocking the breakdown of alcohol in the body.


Q: How long after starting Antietanol will it take to notice the effects if alcohol is consumed?

Official product information states that the drug must be taken after at least 12 hours of complete abstinence from alcohol. Disulfiram is known to be slowly absorbed from the gastrointestinal tract. The drug is gradually absorbed, and the deterrent effect is intended to be in place once the regular daily regimen has been established.


Q: How long do the effects of Antietanol last in the body after the last dose?

Disulfiram is slowly eliminated from the body. Due to the way it works, the potential for a severe disulfiram-alcohol reaction (DAR) persists for up to 14 days after the last dose is taken. For this reason, official warnings indicate that alcohol must be avoided for this entire period.


Q: Can elderly patients use Antietanol without special dosage adjustments?

Regulatory documents indicate that dose selection for elderly patients should be cautious, and official guidance indicates that treatment should generally be initiated at the low end of the dosing range. This cautious approach is recommended because older adults may have a greater frequency of decreased function in organs like the liver or kidneys.


Q: Is Antietanol safe for people with diabetes mellitus?

Official information indicates that co-administration with oral hypoglycemic medications (used for diabetes) requires careful clinical monitoring. The patient's healthcare provider must assess the necessity for this monitoring, as potential drug interactions have been noted.


Q: Is there any research on Antietanol's use in combination with counseling or therapy?

Official regulatory documents indicate that Antietanol is specifically intended to be used as an adjunct, or supportive measure. This supportive role is alongside other measures, typically including psychotherapeutic treatment such as counseling or therapy, and the drug is intended for highly motivated patients.


Q: Has Antietanol been studied for conditions other than alcoholism?

The primary approved indication for Antietanol is alcoholism. However, the mechanism of action involves the inhibition of dopamine beta-hydroxylase (DBH) as well as the enzyme related to alcohol. Research exploring the effects of DBH inhibition has been conducted in other therapeutic areas, though the drug remains only approved for alcohol use disorder.


Q: Where is Antietanol metabolized in the body?

The drug is first converted into an active form, diethyldithiocarbamate, in the stomach. It is then further broken down into other compounds in the body. Because of this metabolism, official documents emphasize the potential risk of hepatic toxicity (damage to the liver) and require monitoring.


Q: Is it possible to have an allergic reaction to Antietanol or its ingredients?

Yes, official safety information lists hypersensitivity to Antietanol (Disulfiram) or related compounds (thiuram derivatives) as a formal contraindication. Allergic reactions, such as skin eruptions and dermatitis, have also been reported as possible adverse effects.


Q: What are the signs of a serious Disulfiram-Alcohol reaction (DAR)?

A serious reaction can manifest as severe symptoms including flushing, throbbing headache, nausea, vomiting, chest pain, difficulty breathing, and a dangerous drop in blood pressure (hypotension). Regulatory guidance often includes a recommendation that patients carry an Identification Card that describes the drug and necessary emergency information.


Q: Why do some sources mention Antietanol being studied as a Dopamine beta-hydroxylase inhibitor?

Regulatory documents explicitly describe the inhibition of the enzyme dopamine beta-hydroxylase (DBH) as a secondary pharmacological mechanism of the drug. This action changes the balance of key neurotransmitters in the body and contributes to its systemic effects.


Q: What should be avoided in terms of food products (sauces, vinegars) that might trigger a reaction?

Official warnings specify that all sources of alcohol must be strictly avoided. This includes obvious sources like alcoholic beverages, but also common products like certain sauces, vinegars, and extracts that may contain alcohol as an ingredient.


Q: Why do people sometimes experience skin rashes when taking Antietanol?

Official safety information lists skin eruptions and allergic dermatitis as reported adverse reactions. These effects have sometimes been observed, particularly during the first one to two weeks of beginning treatment.


Q: Is Antietanol safe for individuals with hypothyroidism (underactive thyroid)?

Regulatory patient information lists an under-active thyroid as a medical problem that should be discussed with a physician before beginning treatment. This indicates that the patient’s healthcare provider must consider this condition and determine if any additional monitoring is required.


Q: Does Antietanol influence the body's rate of alcohol elimination?

Official clinical pharmacology information indicates that the drug does not appear to influence the rate of elimination of alcohol itself from the body. Its effect is solely to block the next metabolic step, which is the breakdown of the toxic intermediate compound, acetaldehyde.


Q: Will I develop a tolerance to Antietanol over time, reducing its effect?

Official clinical information states that prolonged administration of Disulfiram does not produce tolerance in patients. Furthermore, some clinical observations have suggested that patients may become increasingly sensitive to alcohol over the course of treatment.


Q: Can using Antietanol affect one's libido or cause impotence?

Official safety documents list decreased libido and impotence as possible adverse effects. These side effects have sometimes been reported, often during the initial two weeks of therapy.


Q: What is the risk of a reaction if I accidentally use a product like alcoholic hand sanitizer?

Official warnings recommend caution regarding the use of external products that may contain alcohol, such as hand sanitizers, after-shave lotions, or rubbing alcohol. If alcohol is absorbed through the skin, it may potentially cause local symptoms like redness, headache, or nausea.


Q: Is it normal to feel lightheaded (orthostatic hypotension) when starting this medication?

While drowsiness is a common side effect of Antietanol, lightheadedness (a symptom of hypotension) is listed as a potential part of the severe Disulfiram-Alcohol Reaction (DAR). It is not typically listed as a common standalone side effect when the drug is taken without alcohol.


Q: Can Antietanol interact with drugs used for anxiety or sleep?

Official documents warn that Antietanol adds to the effects of other CNS depressants, which includes many medications used for anxiety or sleep. Additionally, the drug may increase the blood levels of certain anti-anxiety drugs by slowing their metabolism.


Q: What are the signs that my liver function might be affected by Antietanol?

Due to the risk of liver damage (hepatotoxicity), patients are advised to watch for symptoms like fatigue, weakness, loss of appetite, nausea, vomiting, yellowing of the skin or eyes (jaundice), or dark urine. If these signs occur, regulatory documents indicate that a healthcare provider should be notified right away.


Q: Does the medication need to be stored at a specific temperature?

Yes, official guidance requires the medication to be stored at Controlled Room Temperature (between 68° and 77°F). The container must also be kept tightly closed to maintain the integrity and safety of the medication.


Q: What information should I share with a new doctor or dentist about taking Antietanol?

It is important to inform all healthcare professionals, including new doctors or dentists, about taking Antietanol. This is critical because of the potential for drug interactions (e.g., with blood thinners) and the additive effects of CNS depressants, which can be found in some medications or anesthetics.


Q: Does Antietanol carry any risk for individuals with pre-existing kidney problems (nephritis)?

While kidney disease is not listed as a formal contraindication, regulatory guidance recommends that dose selection for older patients should be cautious due to the greater frequency of decreased renal (kidney) function in that population. This information suggests that kidney function is a consideration that a healthcare provider must assess.

How should Antietanol be stored and disposed of?

How to Store and Dispose of Antietanol (Disulfiram)

The storage and disposal of Antietanol tablets are strictly governed by regulatory requirements to maintain product integrity and safety.

Official Storage Conditions

Requirement Specific Condition
Temperature Range Store at 20° to 25°C (68° to 77°F) (USP Controlled Room Temperature).
Container Protection The container must be kept tightly closed to protect the contents.
Child Safety The medication must be stored out of the reach of children.

Official Disposal Rules

Patients must dispose of any unused or expired Antietanol product according to local regulations. Consult with a pharmacist or local waste management facility for the proper disposal procedure, as discarding medication via household trash or wastewater may be prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antietanol found in:

A-Z Index: